Revenue

The retail REIT reports record-breaking leasing and strong profits for 2025, while executing a strategic portfolio overhaul and setting a confident tone for 2026.

A new 'longevity center' in Naperville signals a growing trend in proactive health, but what does this mean for the Chicago wellness landscape?

Twilio reports a landmark year of GAAP profitability and robust growth, signaling a strategic pivot to AI as it guides for a billion in 2026 cash flow.

Despite Q4 headwinds, the auto supplier's massive EV wins and deep focus on China fuel an ambitious 2026 forecast for double-digit profitability.

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

Investors and patients await Puma Bio's Q4 results, focusing on NERLYNX sales performance and crucial updates on its promising alisertib cancer pipeline.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

The industrial giant posted strong 2025 results and a cautious 2026 outlook, banking on its execution strategy and key acquisitions in high-growth markets.

A jury verdict against Olin Corporation in a contract dispute with Shintech will cost the chemical giant $185 million and raises industry-wide questions.

Forward Industries' radical crypto pivot is a wild ride. Staking revenue is up 4x, but a market downturn triggered a staggering half-billion-dollar loss.

The pet insurance giant swung to a major profit in 2025, but a closer look reveals a complex strategy of focused growth and rising acquisition costs.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

With a promising heart failure drug in trials, the biotech aims to woo investors at the Oppenheimer conference to fund its attack on age-related diseases.

The SaaS firm posts strong net income and recurring revenue growth from its B2B platform, offsetting a decline in its transactional business.

The streaming pioneer smashed Q4 estimates and returned to full-year profitability, signaling a strong 2026 with ambitious growth targets for its ad platform.

Yelp posted record 2025 revenue but forecasts lower 2026 profits as it invests heavily in an AI transformation, including acquiring Hatch and partnering with OpenAI.

Brazil's fintech leader reports a record R$5.2B adjusted net income for 2025, outlining a strategy that pairs AI with human advisors to win the market.

Celcuity adds Seagen commercial veteran Charles Romp to its board, a strategic move signaling its pivot from R&D to market readiness for gedatolisib.

A pioneering project in Alberta combines distributed capture with advanced MOF materials to tackle emissions from natural gas, signaling a new era for industry.